Targeting neurodegenerative disease with a novel device
Longevity Technology - 19-Feb-2020Foundation of the new therapies mechanism is to access and control the compounds of CSF
Join the club for FREE to access the whole archive and other member benefits.
Strategic business leader with 20 years of demonstrated success in the medical device industry
See also: EnClear Therapies - Device-based therapeutic solutions targeting neurodegenerative disease
Details last updated 23-Feb-2020
Foundation of the new therapies mechanism is to access and control the compounds of CSF